Prestige BioPharma Limited (KRX:950210)

Prestige BioPharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	167,067	103,966	113,582	137,620	396,635	-
Market Cap Growth	59.39%	-8.47%	-17.47%	-65.30%	-	-
Enterprise Value	202,206	44,042	-6,736	-150,494	-63,944	-
Last Close Price	13900.00	8650.00	9450.00	11450.00	33000.00	-
PE Ratio	-	-	6.47	-	-	-
Forward PE	-	12.01	12.01	12.01	-	-
PS Ratio	28.47	150.88	701.81	-	-	-
PB Ratio	0.34	0.20	0.21	0.32	0.69	-
P/TBV Ratio	0.48	0.26	0.28	0.32	0.69	-
EV/Sales Ratio	34.45	63.92	-	-	-	-
Debt / Equity Ratio	0.36	0.20	0.21	0.01	0.01	0.02
Debt / EBITDA Ratio	-	-	9.11	-	-	-
Asset Turnover	0.01	0.00	0	-	-	-
Inventory Turnover	0.09	0.10	0.01	-	-	-
Quick Ratio	1.35	1.57	2.24	7.26	32.70	5.71
Current Ratio	1.47	1.72	2.31	7.46	32.74	5.88
Return on Equity (ROE)	-11.71%	-10.38%	-0.59%	-42.08%	-2.07%	-15.29%
Return on Assets (ROA)	-5.41%	-5.35%	0.10%	-13.89%	-3.01%	-6.12%
Return on Capital (ROIC)	-6.11%	-6.07%	0.12%	-15.08%	-3.18%	-7.41%
Return on Capital Employed (ROCE)	-	-	0.20%	-	-	-
Earnings Yield	-17.87%	-31.66%	15.47%	-153.65%	-1.86%	-
FCF Yield	-54.47%	-65.49%	-95.65%	-74.36%	-4.13%	-
Buyback Yield / Dilution	0.07%	-	-	-16.46%	-20.98%	-7.27%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.